ATLASDexCom (DXCM) earnings date: expected January 25–31
DexCom (DXCM) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 25–31. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on DXCM
| Last price | $82.29 (+3.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.2% |
| Earnings beat history | Beat the EPS estimate in 6 of the last 6 reports |
These figures come from the same calibrated model and valuation as the DexCom stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 25–31 (estimate). One email the day before, with ATLAS’s read on DexCom. You can switch it off at any time.
Alert me before DXCM reportsFree to start. Creating an account takes under a minute.
DXCM earnings at a glance
| Next report | Not announced · expected around January 25–31 (ATLAS estimate) |
|---|---|
| Last report | Oct 29, 2026 · Beat |
| Beat rate (last 6 reports) | 6 of 6 (100%) |
| Average EPS surprise | +11.4% |
| Average move around a report | ±7.8% (last 5) |
| Sector | Healthcare · Medical Devices |
The expected window is an ATLAS estimate: it takes the typical gap between DexCom’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
DexCom earnings history: last 6 reports
DexCom last reported on Oct 29, 2026: EPS of $0.73 against an estimate of $0.66 (+10.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | $0.66 | $0.73 | +10.6% | Beat | – |
| Jul 30, 2026 | $0.61 | $0.70 | +14.8% | Beat | +11.1% |
| Apr 30, 2026 | $0.47 | $0.56 | +19.2% | Beat | +6.6% |
| Apr 10, 2026 | -$0.16 | -$0.14 | +12.5% | Beat | -3.9% |
| Feb 12, 2026 | $0.65 | $0.68 | +4.6% | Beat | +2.7% |
| Oct 30, 2025 | $0.57 | $0.61 | +7.0% | Beat | -14.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for DXCM
See the fair value, the probability range and the earnings history of DexCom on its ATLAS page.
DexCom (DXCM) stock analysisPlans from €3.99 a month.
DexCom earnings: frequently asked questions
When is DexCom (DXCM) next earnings date?
DexCom has not announced its next report. Its last 4 reports came Oct 29, 2026, Jul 30, 2026, Apr 30, 2026, Feb 12, 2026, so ATLAS estimates the next one around January 25–31. This is an estimate based on that pattern, not a confirmed date.
How often does DXCM beat earnings estimates?
Of its last 6 reports with a recorded result, DexCom beat the EPS estimate 6 times; the average surprise was +11.4%. Past results do not predict the next one.
How much does DXCM move around earnings?
Over its last 5 reports the stock moved an average of 7.8% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did DexCom beat earnings estimates last quarter?
DexCom last reported on Oct 29, 2026: EPS of $0.73 against an estimate of $0.66 (+10.6% surprise), a beat.
How much does DXCM usually move in a day?
On a normal trading day the ATLAS model puts DXCM’s one-day range at about ±2.2%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer